Bataille R - Search Results

1

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma.

Pellat-Deceunynck C, Barillé S, Jego G, Puthier D, Robillard N, Pineau D, Rapp MJ, Harousseau JL, Amiot M, Bataille R. Pellat-Deceunynck C, et al. Among authors: bataille r. Leukemia. 1998 Dec;12(12):1977-82. doi: 10.1038/sj.leu.2401211. Leukemia. 1998. PMID: 9844928

2

CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.

Robillard N, Avet-Loiseau H, Garand R, Moreau P, Pineau D, Rapp MJ, Harousseau JL, Bataille R. Robillard N, et al. Among authors: bataille r. Blood. 2003 Aug 1;102(3):1070-1. doi: 10.1182/blood-2002-11-3333. Epub 2003 Apr 17. Blood. 2003. PMID: 12702507 Free article.

3

A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy.

Bataille R, Robillard N, Pellat-Deceunynck C, Amiot M. Bataille R, et al. Immunol Rev. 2003 Aug;194:105-11. doi: 10.1034/j.1600-065x.2003.00039.x. Immunol Rev. 2003. PMID: 12846811 Review.

4

Phenotypic characterization of the human myeloma cell growth fraction.

Robillard N, Pellat-Deceunynck C, Bataille R. Robillard N, et al. Among authors: bataille r. Blood. 2005 Jun 15;105(12):4845-8. doi: 10.1182/blood-2004-12-4700. Epub 2005 Mar 1. Blood. 2005. PMID: 15741217 Free article.

5

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.

Bataille R, Jégo G, Robillard N, Barillé-Nion S, Harousseau JL, Moreau P, Amiot M, Pellat-Deceunynck C. Bataille R, et al. Haematologica. 2006 Sep;91(9):1234-40. Haematologica. 2006. PMID: 16956823 Review.

6

CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis.

Bataille R, Pellat-Deceunynck C, Robillard N, Avet-Loiseau H, Harousseau JL, Moreau P. Bataille R, et al. Leuk Res. 2008 Mar;32(3):379-82. doi: 10.1016/j.leukres.2007.07.016. Epub 2007 Sep 4. Leuk Res. 2008. PMID: 17767956

7

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.

Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau JL, Rapp MJ, Juge-Morineau N, Wijdenes J, Amiot M. Pellat-Deceunynck C, et al. Among authors: bataille r. Blood. 1994 Oct 15;84(8):2597-603. Blood. 1994. PMID: 7522634 Free article.

8

Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization.

Pellat-Deceunynck C, Barillé S, Puthier D, Rapp MJ, Harousseau JL, Bataille R, Amiot M. Pellat-Deceunynck C, et al. Among authors: bataille r. Cancer Res. 1995 Aug 15;55(16):3647-53. Cancer Res. 1995. PMID: 7543019

9

The retinoblastoma susceptibility gene RB-1 in multiple myeloma.

Juge-Morineau N, Harousseau JL, Amiot M, Bataille R. Juge-Morineau N, et al. Among authors: bataille r. Leuk Lymphoma. 1997 Jan;24(3-4):229-37. doi: 10.3109/10428199709039011. Leuk Lymphoma. 1997. PMID: 9156653 Review.

10

Multiple myeloma.

Bataille R, Harousseau JL. Bataille R, et al. N Engl J Med. 1997 Jun 5;336(23):1657-64. doi: 10.1056/NEJM199706053362307. N Engl J Med. 1997. PMID: 9171069 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters